FDA OKs drug-eluting eye implant from Genentech

2021-10-25

The FDA has given approval to Genentech for its Susvimo injection, a drug-eluting eye implant that is used to treat macular degeneration. "We believe that Susvimo can help people with wet AMD preserve their vision while potentially alleviating the treatment burden associated with current standards of care," said Genentech's Head of Global Product Development and Chief Medical Officer Levi Garraway.

Full story:

AdvaMed SmartBrief

Medical devices, health care information systems and diagnostic products

Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart.